Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-16

Clinical Trial Update: Efficacy Study of Adalimumab to Treat Interstitial Cystitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adalimumab for interstitial cystitis has completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: ICStudy, LLC | Conditions: Interstitial Cystitis | Phase 3 | Status: COMPLETED | Results posted: 2015-07-16